Compare Amphastar Pharmaceuticals Inc (AMPH) vs Marathon Digital Holdings Inc (MARA) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

MARA Holdings trades at $12.60, down 4.69% on the day, amid mixed signals. The stock shows a bullish technical trend with strong support at $12, while fundamentals reveal deep losses with a net income margin of -234.83% in 2026. Recent news highlights a strategic pivot to AI infrastructure, including a Texas land acquisition adding 2 GW power capacity, driving investor optimism despite earnings misses.

Outlook hinges on successful execution of AI data center expansion, offering growth potential but carrying high execution risk. Analysts maintain a $17.88 price target (50% buy rating), yet persistent cash burn and competitive pressures pose significant downside risks. Stock appears speculative, balancing transformative opportunities against substantial financial challenges.